TOSCANO, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 54
NA - Nord America 31
AF - Africa 20
AS - Asia 5
OC - Oceania 2
Totale 112
Nazione #
FR - Francia 27
US - Stati Uniti d'America 27
CI - Costa d'Avorio 20
IT - Italia 13
CA - Canada 4
GB - Regno Unito 4
IE - Irlanda 4
FI - Finlandia 3
AU - Australia 2
CN - Cina 2
GR - Grecia 2
VN - Vietnam 2
DK - Danimarca 1
JP - Giappone 1
Totale 112
Città #
Abidjan 20
Columbus 9
Catania 4
Dublin 4
Ashburn 3
New York 3
Outremont 3
Paris 3
Aci Catena 2
Boardman 2
Chingford 2
Dong Ket 2
Helsinki 2
Melbourne 2
Sale 2
Thessaloniki 2
Copenhagen 1
Council Bluffs 1
Denver 1
Des Moines 1
Lappeenranta 1
Milpitas 1
Nashville 1
Priolo Gargallo 1
Rome 1
Thornhill 1
Tokyo 1
Totale 76
Nome #
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort, file dfe4d22c-9893-bb0a-e053-d805fe0a78d9 23
Biomarcatori diagnostici e prognostici nella Sclerosi Multipla: un approccio multidimensionale, file 4f28db6b-38d9-407f-8a54-497023abf9f3 22
Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 era, file c528ce0f-b8bd-465e-881b-58b7bcb3f313 11
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature, file d2a47064-7ba0-45ff-873c-5b1fd343c82f 11
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series, file bf71bb0a-5584-42e6-bb63-11a40c7ba33c 7
Rituximab for the treatment of multiple sclerosis: a review, file 83a060c8-348e-42e4-a7fd-3ca410bc3b70 6
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point, file 41f74f38-04ff-4d94-9aa9-225f9ccdda3c 5
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY), file c1d4c95a-28c9-49fe-9baa-0adf57168da4 5
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study, file ebf1b412-8dec-4d42-b79b-60d8a3741dd0 5
CSF biomarkers in multiple sclerosis: beyond neuroinflammation, file 059d6de5-d871-43a1-a4cc-5b19f2f620cc 4
Correction to: Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID‑19 era, file 2e87a1c2-a403-4995-8816-3b87aec11660 4
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience, file b8b7d177-3446-474d-9679-c2ec84553092 3
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study, file 3e6c6e3f-7e83-42da-a73c-2513520a35fa 1
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients, file 43b54257-e2cf-4099-82fb-3b54620cf7d6 1
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset, file 43f21db5-a4b2-40d1-a285-e05ef63df1c3 1
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis, file 5c705f1e-a9c9-4841-8e98-d1a55c02764c 1
Letter to the editors: comment on “Emerging themes in idiopathic intracranial hypertension”, file e8347f0c-e411-49df-8629-429392b5976f 1
An update on the pharmacological management of pain in patients with multiple sclerosis, file f28080f7-ced3-495a-ba4a-075bcf403199 1
Totale 112
Categoria #
all - tutte 444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/20222 0 0 0 1 0 0 0 1 0 0 0 0
2022/202315 0 0 0 0 0 2 0 2 4 1 5 1
2023/202492 2 14 0 1 3 17 9 12 7 12 15 0
Totale 112